NO961809L - Ny drikk - Google Patents

Ny drikk

Info

Publication number
NO961809L
NO961809L NO961809A NO961809A NO961809L NO 961809 L NO961809 L NO 961809L NO 961809 A NO961809 A NO 961809A NO 961809 A NO961809 A NO 961809A NO 961809 L NO961809 L NO 961809L
Authority
NO
Norway
Prior art keywords
pct
composition
date
sec
energy supply
Prior art date
Application number
NO961809A
Other languages
English (en)
Other versions
NO961809D0 (no
NO314824B1 (no
Inventor
Thomas Olin
Original Assignee
Gramineer Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20391686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO961809(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gramineer Ab filed Critical Gramineer Ab
Publication of NO961809D0 publication Critical patent/NO961809D0/no
Publication of NO961809L publication Critical patent/NO961809L/no
Publication of NO314824B1 publication Critical patent/NO314824B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385Concentrates of non-alcoholic beverages
    • A23L2/39Dry compositions
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/68Acidifying substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/804Low calorie, low sodium or hypoallergic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/81Energy rations, e.g. emergency rations, survival rations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Tea And Coffee (AREA)
  • Manufacture Of Tobacco Products (AREA)
NO19961809A 1993-11-09 1996-05-03 Drikk og törr sammensetning NO314824B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9303691A SE9303691D0 (sv) 1993-11-09 1993-11-09 New beverage
PCT/SE1994/001048 WO1995012991A1 (en) 1993-11-09 1994-11-08 New beverage

Publications (3)

Publication Number Publication Date
NO961809D0 NO961809D0 (no) 1996-05-03
NO961809L true NO961809L (no) 1996-06-24
NO314824B1 NO314824B1 (no) 2003-06-02

Family

ID=20391686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19961809A NO314824B1 (no) 1993-11-09 1996-05-03 Drikk og törr sammensetning

Country Status (12)

Country Link
US (1) US5817364A (no)
EP (1) EP0727947B1 (no)
JP (1) JPH09504945A (no)
CN (1) CN1076183C (no)
AT (1) ATE247909T1 (no)
AU (1) AU685882B2 (no)
CA (1) CA2176134A1 (no)
DE (1) DE69433092D1 (no)
FI (1) FI961947A (no)
NO (1) NO314824B1 (no)
SE (1) SE9303691D0 (no)
WO (1) WO1995012991A1 (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100287A (en) * 1997-11-13 2000-08-08 University Of Florida Materials and methods for enhancing muscle performance and recovery from fatigue
US6214390B1 (en) 1997-11-17 2001-04-10 Robert E. Weinstein Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6514545B1 (en) 1997-11-17 2003-02-04 Robert E. Weinstein Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6013290A (en) * 1997-11-17 2000-01-11 Weinstein; Robert E. Assemblage of nutrient beverages and regimen for enhancing convenience, instruction, and compliance with exercise supplementation
US6221910B1 (en) 1999-07-22 2001-04-24 The University Of New Mexico Glutamine containing oral replacement solution
US7056950B2 (en) * 2001-02-14 2006-06-06 Matthias Rath Compositions of biochemical compounds involved in bioenergy metabolism of cells
US6989171B2 (en) * 2001-04-02 2006-01-24 Pacifichealth Laboratories, Inc. Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
US7740893B2 (en) * 2001-04-02 2010-06-22 Mott's Llp Sports drink composition for enhancing glucose uptake into the muscle and extending endurance during physical exercise
SE0201713D0 (sv) 2001-11-23 2002-06-06 Gramineer Internat Ab New methods and use III
WO2005002567A1 (en) * 2003-07-01 2005-01-13 Essentys Ab Use of alpha-ketoglutaric acid for the treatment of malnutrition or high plasma glucose condition
SE0301947D0 (sv) * 2003-07-01 2003-07-01 Gramineer Internat Ab New method and uses
PL368572A1 (en) * 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
US20060134300A1 (en) * 2004-12-20 2006-06-22 Newman Arnold L Nutritional supplement for caffeine-containing beverages
AU2006316059A1 (en) * 2005-11-15 2007-05-24 Entress Ab Medicament for use in connection with cartilage impairment
JP2009533433A (ja) * 2006-04-12 2009-09-17 アレクサンダー,ランヤ,エル. ピルビン酸アルキルエステルを含む組成物とその使用
PL379512A1 (pl) * 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie
US7566463B2 (en) * 2006-05-03 2009-07-28 C. B. Fleet Company Oral rehydration compositions
WO2009005379A1 (en) * 2007-07-03 2009-01-08 Danuta Kruszewska New medical applications of alpha-ketoglutarate
WO2009018166A1 (en) * 2007-07-27 2009-02-05 Nutritional Network, Inc. Exercise performance and recovery formulations
EP2098124A1 (en) 2008-03-03 2009-09-09 Nestec S.A. Carbohydrate gel
US20090280229A1 (en) * 2008-05-07 2009-11-12 Constantine Wendy L Method and apparatus for manufacturing protein beverages
EP2177113A1 (en) * 2008-10-15 2010-04-21 Nestec S.A. Improved liver glycocen synthesis
DE102009016119A1 (de) * 2009-04-03 2010-10-14 Evonik Degussa Gmbh Nahrungsergänzungsmittel enthaltend alpha-Ketosäuren zur Unterstützung der Diabetestherapie
US20150157660A1 (en) * 2013-12-10 2015-06-11 Lifewave, Inc. Nutritional product composition for energy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE462463C (de) * 1928-07-11 Constanz Petersmann Nachgiebige Streckenauskleidung aus Natursteinen
US4001448A (en) * 1973-05-14 1977-01-04 General Foods Corporation Beverage mix and method of manufacturing same
US4309417A (en) * 1980-07-10 1982-01-05 Stauffer Chemical Company Protein fortified isotonic beverages
SE8704217D0 (sv) * 1987-10-29 1987-10-29 Vinnars Erik Ab Aminosyrakomposition for parenteral neringstillforsel
SE462463B (sv) * 1988-12-02 1990-07-02 Decken Alexandra V D Livs- och fodermedel innehaallande ketosyror
DE3943424A1 (de) * 1989-12-30 1991-07-04 Nephro Medica Pharma Infusions- und injektionsloesung zur intravenoesen verabreichung
SE9003844L (sv) * 1990-12-03 1992-06-04 Kabi Pharmacia Ab Naeringstillsats
SE9201584D0 (sv) * 1992-05-20 1992-05-20 Vinnars Erik Ab Use of alpha-ketoglutarate
US5270297A (en) * 1992-07-23 1993-12-14 Metagenics, Inc. Endurance and rehydration composition

Also Published As

Publication number Publication date
US5817364A (en) 1998-10-06
EP0727947B1 (en) 2003-08-27
JPH09504945A (ja) 1997-05-20
NO961809D0 (no) 1996-05-03
CA2176134A1 (en) 1995-05-18
WO1995012991A1 (en) 1995-05-18
ATE247909T1 (de) 2003-09-15
FI961947A0 (fi) 1996-05-08
NO314824B1 (no) 2003-06-02
CN1076183C (zh) 2001-12-19
AU685882B2 (en) 1998-01-29
SE9303691D0 (sv) 1993-11-09
CN1136266A (zh) 1996-11-20
AU1037895A (en) 1995-05-29
FI961947A (fi) 1996-06-13
DE69433092D1 (de) 2003-10-02
EP0727947A1 (en) 1996-08-28

Similar Documents

Publication Publication Date Title
NO961809D0 (no) Ny drikk
ES2083595T3 (es) Derivados de indol que inhiben la biosintesis de leucotrienos.
PL309348A1 (en) Application of an agent called riluzole in therapy of neurological damages caused by or associated with injuries
WO2003020202A3 (en) Method for reducing hypertension and heart failure
SE9404196D0 (sv) New antithrombotic formulation
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
CA2002859A1 (en) Method of treating epithelial disorders
ATE311844T1 (de) Nicht-irritierende zusammensetzung zur behandlung des aknes und andere hautzustände
GR3030371T3 (en) Triazole compounds and their use as dopamine-d 3?-ligands
DE69431601T2 (de) Neue verwendung von dexmedetomidin
ES2127558T3 (es) Agentes conservantes.
GR3031321T3 (en) Isothiourea derivatives as no synthase inhibitors
ATE226058T1 (de) Verwendung von lysin zur behandlung des haarausfalls
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
SE9402880D0 (sv) New peptide derivatives
ATE123415T1 (de) Behandlung anstrengungsbedingter pulmonarer blutungen bei tieren.
GR3033822T3 (en) Novel monofunctionalised edta, dtpa and ttha derivatives and their use in medical diagnosis and therapy
DE69427116T2 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
HRP930833A2 (en) Water soluble retinoids
SE9404438D0 (sv) New process
RU95102777A (ru) Способ лечения реперфузного повреждения и "оглушения" миокарда
AU3295495A (en) Method for the treatment or prophylaxis of endo- and ectoparasitic infestations in dogs
ZA9427B (en) Use of riluzole for promoting restoration following radiation
BG102974A (en) Ethene-containing solutions and their use in methods of treatment or prevention
GR3027682T3 (en) 4-guanidinobutyramide for improving blood circulation.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees